Dr Mandal, from the University of California, presented research she conducted with colleagues on ways to alleviate the disproportionate levels of rheumatology care among communities of color and rural populations.
Dr Mandal, from the University of California, presented research she conducted with colleagues on ways to alleviate the disproportionate levels of rheumatology care among communities of color and rural populations.
Dr Fleishmann reviews a post hoc analysis he and colleagues conducted of the SELECT phase 3 trial of upadacitinib in rheumatoid arthritis and the safety of JAK inhibitors among RA patients at risk for cardiovascular events.
Dr Fleishmann reviews a post hoc analysis he and colleagues conducted of the SELECT phase 3 trial of upadacitinib in rheumatoid arthritis and the safety of JAK inhibitors among RA patients at risk for cardiovascular events.
